Promote a Clinical Trial


Study of Atezolizumab in Relapsed or Refractory Hodgkin Lymphoma

This is a study with the purpose of studying the safety and efficacy of the study drug Atezolizumab in patients with relapsed or refractory Hodgkin lymphoma (HL). Atezolizumab could shrink cancer but it could also cause side effects. This study will also test any good and bad effects the study drug. Other aims include studying biomarkers that will help researchers understand how the drug works.

Sponsored by: Memorial Sloan Kettering Cancer Center